StockNews.com Initiates Coverage on Jaguar Health (NASDAQ:JAGX)

StockNews.com assumed coverage on shares of Jaguar Health (NASDAQ:JAGX) in a report published on Monday. The brokerage issued a sell rating on the biotechnology company’s stock.

Jaguar Health Stock Performance

Shares of JAGX stock opened at $0.17 on Monday. The stock has a fifty day moving average of $0.09 and a 200 day moving average of $0.18. Jaguar Health has a 52 week low of $0.05 and a 52 week high of $1.22. The company has a quick ratio of 1.34, a current ratio of 2.00 and a debt-to-equity ratio of 6.33.

Jaguar Health Company Profile

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.